ATLANTA, GA – – (Globe Newswire – February 18, 2025) – – A shareholder class action lawsuit has been filed against TransMedics Group, Inc. (“TransMedics” or the “Company”) (NASDAQ: TMDX). The lawsuit alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material adverse facts about TransMedics’s business, operations, and prospects, including allegations that: (1) TransMedics used kickbacks, fraudulent overbilling, and coercive tactics to generate business and revenue; (2) TransMedics engaged in unsafe practices and hid safety issues and generally lacked safety oversight; and (3) the foregoing subjected TransMedics to heightened risk of scrutiny and regulatory risk.

If you bought shares of TransMedics between February 28, 2023 and January 10, 2025, and you suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com, by toll-free telephone at (888) 508-6832 or you may visit the firm’s website at www.holzerlaw.com/case/transmedics-group/ to learn more.

The deadline to ask the court to be appointed lead plaintiff in the case is April 15, 2025.